Arati S Desai

6PUBLICATIONS
132CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

|Jan 31, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma.

Jacob E Till, Nicholas J Seewald, Zachariya Yazdani

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Nov 08, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.

Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak

|Jul 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.

Spyridon Bakas, Chiharu Sako, Hamed Akbari

|Jul 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

Donald M O'Rourke, MacLean P Nasrallah, Arati Desai

Pageof 1

Frequent Collaborators

3 joint publications

Donald M O'Rourke

3 joint publications

Patrick Y Wen

3 joint publications

Keith L Ligon

3 joint publications

Stephen J Bagley